Connect with us

Health

Ozempic, other weight-loss drugs may strengthen New Year's resolutions, experts say: Health goal 'boost'

Published

on

Ozempic, other weight-loss drugs may strengthen New Year's resolutions, experts say: Health goal 'boost'

Read this article for free!

Plus get unlimited access to thousands of articles, videos and more with your free account!

Please enter a valid email address.

By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your email and follow the instructions provided.

New year, new motivation?

For 2024, some of the most common New Year’s resolutions include adopting fitness and diet regimens, plus losing weight, according to a Forbes survey.

Advertisement

As weight-loss medications like Ozempic and Wegovy peak in popularity, experts believe these meds could make it more likely that people stick with their resolutions.

OZEMPIC AND WEGOVY WEIGHT LOSS DRUGS COULD HELP REDUCE ALCOHOL USE DISORDER SYMPTOMS, STUDY SUGGESTS

Galit Shokrian, a Los Angeles-based CEO and co-founder of the online weight loss program Trimly, agreed that the widespread use of GLP-1s will impact the way people approach New Year’s goals.

GLP-1 agonists, which include semaglutides, are medications that help to reduce blood sugar and aid in weight loss.

“Semaglutides are a total game-changer in New Year’s resolutions this year,” she told Fox News Digital.

Advertisement

As weight-loss medications like Ozempic and Wegovy peak in popularity moving into the New Year, semaglutide experts believe these meds could make it more likely that people will stick with their resolutions. (iStock; SEBASTIEN BOZON/AFP via Getty Images)

Millions of Americans make resolutions to lose weight each year — but 40% to 50% give up by the end of January, according to Shokrian.

“The introduction of semaglutide and tirzepatide treatments are finally allowing overweight women and men to not only lose the weight, but successfully keep it off,” she said.

(Tirzepatide, another GLP-1 medication, is sold under the brand name Mounjaro.)

OZEMPIC-WEGOVY PILL MAY BE ON THE WAY: TRIAL SHOWS PROMISING RESULTS FOR NEW WEIGHT LOSS TABLET

Advertisement

“They kickstart a new lifestyle for someone who needs a boost in getting to their health goals.”

Losing weight via medication “staves off future health complications, increases confidence, increases sex drive and allows patients to become more active,” Shokrian noted.

Galit Shokrian, co-founder and CEO of Trimly, said semaglutide and tyrzepatide treatments are “finally allowing overweight women and men to not only lose the weight, but successfully keep it off.” (Myles Pettengill III)

Colin Banas, M.D., M.H.A., Virginia-based chief medical officer at the medication data platform DrFirst, said in a statement to Fox News Digital that he’s “never seen a therapy adopted so quickly.”

He said, “Our research shows that 80% of Americans believe more people will take these drugs for weight loss in the future, most stating it will become the norm.”

Advertisement

Semaglutide medications have “transformed” lives, effecting “dramatic results” for people who previously had complications with weight loss, Banas added.

OZEMPIC, WEGOVY AND PREGNANCY RISK: WHAT YOU NEED TO KNOW ABOUT THE ISSUE

Avantika Waring, 9amHealth’s chief medical officer and a trained physician and endocrinologist in San Francisco, noted that these previous complications have led to many failed resolutions.

“So many people make weight-loss resolutions for the New Year but find the months ahead to be challenging and frustrating because weight-loss and lifestyle changes are not easy to maintain,” she told Fox News Digital. 

Wegovy is an injectable prescription weight-loss medicine that has helped people with obesity. (Michael Siluk/UCG/Universal Images Group via Getty Images)

Advertisement

With the aid of semaglutide and related drugs, Waring said people are seeing quicker success with their weight-loss efforts.

“I predict this will get them even more motivated to make resolutions and stick with them, because they’re more likely to see a real impact,” she said.

NEW YEAR’S RESOLUTION IDEAS AND HOW TO CRUSH THEM: 10 STEPS TO TAKE

Insurance plans, said the physician, often require a “demonstrated commitment to lifestyle change” in order for people to access these drugs.

“So it will be even more important to start with a firm commitment to a healthy lifestyle to ‘supercharge’ those New Year’s resolutions,” she said.

Advertisement

Colin Banas, Virginia-based chief medical officer at the medication data platform DrFirst, said he’s “never seen a therapy adopted so quickly.” (DrFirst)

Although semaglutide treatments are “quickly changing the paradigm” for how people approach weight loss, Banas said it’s important to remember that it is “not a magic wand.”

He added, “For sustained weight loss, people will still need to exercise and follow a healthy diet.”

“Semaglutide and tyrzepatide treatments are finally allowing overweight women and men to not only lose the weight, but successfully keep it off.”

A recent study by Morgan Stanley found that weekly exercise doubled — rising from 35% to 71% — after participants began taking weight-loss medication.

Advertisement

Teddy Savage, national lead trainer at Planet Fitness in Maryland, told Fox News Digital that he doesn’t foresee fitness motivation decreasing in 2024.

A Planet Fitness gym in New York is pictured on Nov. 2, 2023. Teddy Savage, national lead trainer at Planet Fitness, told Fox News Digital that he doesn’t foresee fitness motivation decreasing in the New Year. (Michael Nagle/Bloomberg via Getty Images)

“The COVID-19 pandemic opened people’s eyes to the importance of getting and staying healthy, so I’d say more people are making their health a priority,” he said.

“We always see more people committing to their fitness goals in the New Year, which is great,” he added. “We encourage everyone to start slow, set achievable goals and enjoy the journey.”

He also said, “It’s a marathon, not a sprint.”

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Despite the growing popularity and availability of weight-loss drugs, Savage said staying active should remain a priority.

“Physical activity is always a key ingredient to overall health and well-being, and we believe it’s important to prioritize fitness no matter the time of year,” he said.

A recent study by Morgan Stanley found that weekly exercise rose from 35% to 71% after participants began taking weight-loss medication. (iStock)

Savage also noted that mental health is just as important as physical health. “It’s not just how you look, it’s how you feel.”

Advertisement

Said Savage, “Regular exercise benefits your heart, muscles and body, but exercise also has immense mental health benefits. It can help you sleep better, feel less stressed, and ready to tackle all that 2024 brings.”

For optimal wellness, Savage said it’s important to have a “full-body workout consisting of both cardio and strength training while eating a balanced, nutritious diet.”

For more Health articles, visit www.foxnews.com/health.

Advertisement

Health

Weight gain in certain decade of life may be more dangerous, study suggests

Published

on

Weight gain in certain decade of life may be more dangerous, study suggests

NEWYou can now listen to Fox News articles!

Weight management is often treated as a “middle-age” problem, but new research suggests that the pounds you pack on in your 20s may be the most dangerous of your life.

A massive study of more than 620,000 individuals found that the damage from early weight gain is disproportionately high and surprisingly permanent. According to the findings, the younger someone is when obesity sets in, the higher the risk of early mortality.

The study, published in the journal eClinicalMedicine, analyzed data from the Obesity and Disease Development Sweden project.

MEN FACE HIDDEN HEART RISK YEARS EARLIER THAN WOMEN, STUDY SUGGESTS

Advertisement

“The most consistent finding is that weight gain at a younger age is linked to a higher risk of premature death later in life, compared with people who gain less weight,” Tanja Stocks, a professor at Lund University and one of the researchers behind the study, said in a press release.

New research suggests that the pounds you pack on in your 20s may be the most dangerous of your life. (iStock)

Developing obesity between the ages of 17 and 29 was linked to a 70% higher risk of early death compared to weight gain later in life.

Weight gain later in adulthood, between ages 30 and 60, was also linked to higher death rates, but the connections were generally weaker.

HERE’S THE AGE WHEN STRENGTH AND FITNESS BEGIN FADING, LONG-TERM DATA SHOWS

Advertisement

“One possible explanation for why people with early obesity onset are at greater risk is their longer period exposed to the biological effects of excess weight,” Huyen Le, a doctoral student at Lund University and first author of the study, said in the release.

CLICK HERE FOR MORE HEALTH STORIES

When weight gain happens in the 20s, the blood vessels, liver and metabolic systems endure obesity-related strain for decades longer than someone who gains the same weight in their 50s, experts say.

Weight gain later in adulthood, between ages 30 and 60, was also linked to higher death rates, but the connections were generally weaker. (iStock)

The study identified type 2 diabetes as the leading cause of death associated with early-onset obesity. Other significant risks included high-blood pressure, liver cancer in men and uterine cancer in women.

Advertisement

To reach these conclusions, researchers tracked participants’ weight paths across adulthood over more than 50 years, focusing on three specific windows: ages 17 to 29, 30 to 44, and 45 to 60.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Using a body mass index (BMI) of 30 or higher to define obesity, the team compared weight data against Sweden’s national death registry.

After adjusting for a variety of factors, including smoking habits and marital status, the trend showed that becoming obese later in life still carried risks, but the danger compounded the longer people stayed obese.

While type 2 diabetes is the leading risk, early-onset obesity is also tied to higher rates of high-blood pressure and specific cancers. (iStock)

Advertisement

While these findings highlight the “importance of early and sustained obesity prevention strategies,” the researchers noted that other factors come into play, and that increases in risk within a population can be difficult to interpret.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“We shouldn’t get too hung up on exact risk figures,” Stocks said.

“They are rarely entirely accurate, as they are influenced, for example, by the factors taken into account in the study and the accuracy with which both risk factors and outcomes have been measured.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

Because the study was conducted in Sweden, more research is needed to understand the effect of early-onset obesity in other populations, the team noted.

Continue Reading

Health

Best Healthy Foods for Weight Loss After 50, Including Cheese and Bread!

Published

on

Best Healthy Foods for Weight Loss After 50, Including Cheese and Bread!


Advertisement





Best Healthy Foods for Weight Loss and Fat Burn After 50




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Popular weight-loss medications linked to hidden side effects, study finds

Published

on

Popular weight-loss medications linked to hidden side effects, study finds

NEWYou can now listen to Fox News articles!

In a sweeping analysis of more than 400,000 Reddit posts, researchers have revealed some little-known GLP-1 side effects.

GLP-1 receptor agonists — such as semaglutide (Ozempic and Wegovy), and tirzepatide (Mounjaro and Zepbound) — have been most commonly associated with gastrointestinal side effects, such as nausea, vomiting, diarrhea and constipation.

A new study published in Nature Health, however, uncovered some overlooked effects.

SHOULD YOU MICRODOSE OZEMPIC? EXPERTS ARE SPLIT ON RISKS VS BENEFITS

Advertisement

University of Pennsylvania researchers used artificial intelligence to analyze more than five years of Reddit posts from more than 67,000 people taking the popular drugs for diabetes or weight loss.

While clinical trials are still the “gold standard,” the researchers noted that Reddit community feedback reflects a different population.

GLP-1 receptor agonists — such as semaglutide (Ozempic and Wegovy), and tirzepatide (Mounjaro and Zepbound) — have been most commonly associated with gastrointestinal side effects, such as nausea, vomiting, diarrhea and constipation. (iStock)

“People often use medications differently than they’re prescribed, so it’s also important to look at real-world usage, which can diverge from usage in a clinical trial,” lead researcher Neil Sehgal, a PhD student at the University of Pennsylvania, told Fox News Digital. “So there are many possible reasons we’re seeing signals that the trials may have missed.”

Overlooked effects

Nearly half of the users reported one or more side effects. The most common were nausea, vomiting and constipation, which aligned with what clinical trials found, according to Sehgal.

Advertisement

“We’re almost certainly capturing a skewed slice of the full picture.”

“We did notice a few side effects that have not previously been reported for these drugs,” he told Fox News Digital. 

“For example, about 4% of users who described side effects reported menstrual irregularities. Other Redditors described unusual temperature-related symptoms, like chills or hot flashes.”

OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU

Nearly 13% of users also experienced psychiatric symptoms, such as anxiety, depression and insomnia. More than 5% also complained of abdominal pain, acid reflux, headache and dizziness.

Advertisement

“Fatigue was also the second most commonly reported symptom overall, but has met relatively few reporting thresholds in existing trials,” Seghal noted. “This gap between what patients are self-reporting online and what gets captured in trials is really what motivated this whole line of work.”

Clinical context

Dr. Sue Decotiis, a New York City-based board-certified weight-loss physician, noted that many of the reported symptoms, such as disorientation and fatigue, are most likely due to dehydration and hypoglycemia (low blood sugar).

“People often use medications differently than they’re prescribed, so it’s also important to look at real-world usage, which can diverge from usage in a clinical trial,” the lead researcher said. (iStock)

“Patients should be carefully monitored using a structured protocol that ensures proper nutrition and adequate hydration, ideally under the direct supervision of a physician experienced in metabolism and weight loss,” Decotiis, who was not involved in the study, told Fox News Digital. 

“Additionally, body composition analysis can help identify issues such as muscle loss, excessive water loss or insufficient fat loss.”

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

A significant concern, according to the doctor, is that many individuals are accessing these medications through online platforms or without receiving appropriate medical care. 

“In my experience treating thousands of patients with various GLP-1 medications, complications are rare and typically occur only when patients are noncompliant,” she added.

Study limitations

As the data came from Reddit users, who tend to be younger, primarily male and mostly based in the U.S., it may not represent everyone taking these medications, the researchers noted.

“In my experience treating thousands of patients with various GLP-1 medications, complications are rare and typically occur only when patients are noncompliant,” a weight-loss doctor shared. (iStock)

Advertisement

“And even within Reddit, the people who post about their side effects are probably not typical of everyone on the medication,” Sehgal said. “If you had a good experience, you’re less likely to be writing about it online. So we’re almost certainly capturing a skewed slice of the full picture.”

The researchers also noted that the study can’t prove the drug caused the reported symptoms.

CLICK HERE FOR MORE HEALTH STORIES

“To be clear, we can’t say for certain whether these drugs are causing menstrual irregularities,” Sehgal said. “Patients on Reddit aren’t going to self-report every symptom they have, and they may also report things that aren’t actually linked to the medications. So it’s important to treat this as hypothesis-generating signals and do more research.”

The researchers noted that the study can’t prove the drug caused the reported symptoms. (iStock)

Advertisement

The study also didn’t include GLP-1 dosage, duration of the medication and symptoms, or other health conditions the users experienced. There is also the chance that the AI tools misunderstood meanings or context, the researchers noted.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The results must be confirmed with more rigorous research, Sehgal said. “That’s how we’ll get real answers about prevalence and causality, which social media data alone can’t provide.” 

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“These are signals, not conclusions – but I do think it’s always worth talking to your doctor about anything unexpected you’re experiencing while on a new medication, even if you’re not sure if it’s related,” he advised. “So if something feels off, say something.”

Advertisement

Continue Reading

Trending